

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 4.80464473 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.80464473 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 4.72196743 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.72196743 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 4.04701477 |
| 6 | cysteine metabolic process (GO:0006534) | 4.01241945 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.00695471 |
| 8 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.86622473 |
| 9 | positive regulation of granulocyte differentiation (GO:0030854) | 3.83410181 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.82092275 |
| 11 | negative regulation of cell killing (GO:0031342) | 3.82092275 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.75923807 |
| 13 | cellular ketone body metabolic process (GO:0046950) | 3.63609225 |
| 14 | lysine metabolic process (GO:0006553) | 3.63154234 |
| 15 | lysine catabolic process (GO:0006554) | 3.63154234 |
| 16 | bile acid biosynthetic process (GO:0006699) | 3.61821310 |
| 17 | kynurenine metabolic process (GO:0070189) | 3.61790572 |
| 18 | oxygen transport (GO:0015671) | 3.60513497 |
| 19 | iron ion import (GO:0097286) | 3.45701928 |
| 20 | indole-containing compound catabolic process (GO:0042436) | 3.45349714 |
| 21 | indolalkylamine catabolic process (GO:0046218) | 3.45349714 |
| 22 | tryptophan catabolic process (GO:0006569) | 3.45349714 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 3.42810643 |
| 24 | glutamate metabolic process (GO:0006536) | 3.39880259 |
| 25 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.37624697 |
| 26 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.37624697 |
| 27 | high-density lipoprotein particle remodeling (GO:0034375) | 3.36686481 |
| 28 | necroptotic process (GO:0070266) | 3.34377338 |
| 29 | neuronal action potential propagation (GO:0019227) | 3.34225286 |
| 30 | regulation of ARF protein signal transduction (GO:0032012) | 3.33586545 |
| 31 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.30146156 |
| 32 | alpha-linolenic acid metabolic process (GO:0036109) | 3.29077144 |
| 33 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.29039114 |
| 34 | gas transport (GO:0015669) | 3.28829468 |
| 35 | regulation of necroptotic process (GO:0060544) | 3.27000429 |
| 36 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.23996409 |
| 37 | synaptic vesicle maturation (GO:0016188) | 3.23855811 |
| 38 | synaptic vesicle exocytosis (GO:0016079) | 3.22812237 |
| 39 | amino-acid betaine metabolic process (GO:0006577) | 3.20624789 |
| 40 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.20484423 |
| 41 | tryptophan metabolic process (GO:0006568) | 3.20294595 |
| 42 | glutamate secretion (GO:0014047) | 3.19619867 |
| 43 | cellular response to ethanol (GO:0071361) | 3.18542324 |
| 44 | hemoglobin metabolic process (GO:0020027) | 3.15628420 |
| 45 | coenzyme catabolic process (GO:0009109) | 3.13304248 |
| 46 | glyoxylate metabolic process (GO:0046487) | 3.13159591 |
| 47 | ketone body metabolic process (GO:1902224) | 3.09932649 |
| 48 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.08810669 |
| 49 | cellular extravasation (GO:0045123) | 3.06090297 |
| 50 | positive regulation of Rap GTPase activity (GO:0032854) | 3.05497600 |
| 51 | short-chain fatty acid metabolic process (GO:0046459) | 3.05306812 |
| 52 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.04715508 |
| 53 | regulation of gamma-delta T cell activation (GO:0046643) | 3.04429390 |
| 54 | drug transmembrane transport (GO:0006855) | 3.04097714 |
| 55 | aromatic amino acid family metabolic process (GO:0009072) | 3.04066821 |
| 56 | cellular modified amino acid catabolic process (GO:0042219) | 3.03804245 |
| 57 | alpha-amino acid catabolic process (GO:1901606) | 3.03778318 |
| 58 | serine family amino acid catabolic process (GO:0009071) | 3.01264954 |
| 59 | regulation of platelet aggregation (GO:0090330) | 2.99376984 |
| 60 | regulation of fibrinolysis (GO:0051917) | 2.98771699 |
| 61 | bile acid metabolic process (GO:0008206) | 2.98262289 |
| 62 | regulation of protein activation cascade (GO:2000257) | 2.98189563 |
| 63 | response to methylmercury (GO:0051597) | 2.97852947 |
| 64 | urea cycle (GO:0000050) | 2.95553876 |
| 65 | urea metabolic process (GO:0019627) | 2.95553876 |
| 66 | detection of molecule of bacterial origin (GO:0032490) | 2.95332444 |
| 67 | succinate metabolic process (GO:0006105) | 2.95024887 |
| 68 | neurotransmitter secretion (GO:0007269) | 2.94787290 |
| 69 | protein carboxylation (GO:0018214) | 2.94769782 |
| 70 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.94769782 |
| 71 | cellular amino acid catabolic process (GO:0009063) | 2.93730629 |
| 72 | 2-oxoglutarate metabolic process (GO:0006103) | 2.93445029 |
| 73 | oxaloacetate metabolic process (GO:0006107) | 2.93079687 |
| 74 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.92757705 |
| 75 | regulation of synaptic vesicle transport (GO:1902803) | 2.91507368 |
| 76 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.91290792 |
| 77 | neutrophil activation involved in immune response (GO:0002283) | 2.91029784 |
| 78 | reverse cholesterol transport (GO:0043691) | 2.91008295 |
| 79 | detection of other organism (GO:0098543) | 2.90327938 |
| 80 | aspartate family amino acid catabolic process (GO:0009068) | 2.88786838 |
| 81 | sodium ion export (GO:0071436) | 2.86680200 |
| 82 | negative regulation of fibrinolysis (GO:0051918) | 2.86480753 |
| 83 | regulation of triglyceride catabolic process (GO:0010896) | 2.86375774 |
| 84 | negative regulation of type 2 immune response (GO:0002829) | 2.86176739 |
| 85 | neuromuscular process controlling posture (GO:0050884) | 2.85190061 |
| 86 | tyrosine metabolic process (GO:0006570) | 2.85033186 |
| 87 | gamma-aminobutyric acid transport (GO:0015812) | 2.84950197 |
| 88 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.84684791 |
| 89 | plasma lipoprotein particle remodeling (GO:0034369) | 2.84467148 |
| 90 | protein-lipid complex remodeling (GO:0034368) | 2.84467148 |
| 91 | macromolecular complex remodeling (GO:0034367) | 2.84467148 |
| 92 | regulation of granulocyte differentiation (GO:0030852) | 2.82278379 |
| 93 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.80831459 |
| 94 | complement activation, alternative pathway (GO:0006957) | 2.80657684 |
| 95 | definitive hemopoiesis (GO:0060216) | 2.80653754 |
| 96 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.80396265 |
| 97 | erythrocyte development (GO:0048821) | 2.80113061 |
| 98 | cholesterol catabolic process (GO:0006707) | 2.79794411 |
| 99 | sterol catabolic process (GO:0016127) | 2.79794411 |
| 100 | regulation of cholesterol esterification (GO:0010872) | 2.79444053 |
| 101 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.79189212 |
| 102 | nitrogen cycle metabolic process (GO:0071941) | 2.78929149 |
| 103 | regulation of complement activation (GO:0030449) | 2.78563400 |
| 104 | cellular potassium ion homeostasis (GO:0030007) | 2.78463285 |
| 105 | regulation of beta-amyloid formation (GO:1902003) | 2.78309045 |
| 106 | negative regulation of T cell mediated immunity (GO:0002710) | 2.77520217 |
| 107 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.77439746 |
| 108 | ethanol oxidation (GO:0006069) | 2.76977833 |
| 109 | detection of bacterium (GO:0016045) | 2.76755395 |
| 110 | detection of external biotic stimulus (GO:0098581) | 2.75961236 |
| 111 | cellular response to epinephrine stimulus (GO:0071872) | 2.75294410 |
| 112 | programmed necrotic cell death (GO:0097300) | 2.74528961 |
| 113 | NADH metabolic process (GO:0006734) | 2.74388257 |
| 114 | phospholipid efflux (GO:0033700) | 2.72895561 |
| 115 | blood coagulation, intrinsic pathway (GO:0007597) | 2.72581984 |
| 116 | iron coordination entity transport (GO:1901678) | 2.72353786 |
| 117 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.72147805 |
| 118 | mannose metabolic process (GO:0006013) | 2.71880690 |
| 119 | positive regulation of fibroblast migration (GO:0010763) | 2.71721533 |
| 120 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.70376645 |
| 121 | triglyceride homeostasis (GO:0070328) | 2.70147638 |
| 122 | acylglycerol homeostasis (GO:0055090) | 2.70147638 |
| 123 | locomotory exploration behavior (GO:0035641) | 2.68344392 |
| 124 | carnitine metabolic process (GO:0009437) | 2.66997096 |
| 125 | necrotic cell death (GO:0070265) | 2.66348285 |
| 126 | benzene-containing compound metabolic process (GO:0042537) | 2.65537284 |
| 127 | valine metabolic process (GO:0006573) | 2.64581404 |
| 128 | carboxylic acid catabolic process (GO:0046395) | 2.64529893 |
| 129 | organic acid catabolic process (GO:0016054) | 2.64529893 |
| 130 | B cell receptor signaling pathway (GO:0050853) | 2.64131795 |
| 131 | monocarboxylic acid catabolic process (GO:0072329) | 2.64037806 |
| 132 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.62728524 |
| 133 | regulation of necrotic cell death (GO:0010939) | 2.60822536 |
| 134 | fatty acid catabolic process (GO:0009062) | 2.59845684 |
| 135 | peroxisome fission (GO:0016559) | 2.59129277 |
| 136 | Peyers patch development (GO:0048541) | 2.57237112 |
| 137 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.57237112 |
| 138 | regulation of leukocyte degranulation (GO:0043300) | 2.56493989 |
| 139 | dicarboxylic acid catabolic process (GO:0043649) | 2.54303178 |
| 140 | regulation of regulated secretory pathway (GO:1903305) | 2.54068774 |
| 141 | homocysteine metabolic process (GO:0050667) | 2.53866217 |
| 142 | acetyl-CoA metabolic process (GO:0006084) | 2.53782529 |
| 143 | regulation of mast cell degranulation (GO:0043304) | 2.53121963 |
| 144 | drug catabolic process (GO:0042737) | 2.53017554 |
| 145 | fatty acid oxidation (GO:0019395) | 2.52919084 |
| 146 | heme transport (GO:0015886) | 2.52914549 |
| 147 | activation of protein kinase A activity (GO:0034199) | 2.51836330 |
| 148 | fatty acid beta-oxidation (GO:0006635) | 2.50947333 |
| 149 | myeloid cell development (GO:0061515) | 2.50789863 |
| 150 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.50787027 |
| 151 | low-density lipoprotein particle remodeling (GO:0034374) | 2.50268000 |
| 152 | lipid oxidation (GO:0034440) | 2.49714623 |
| 153 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.48783144 |
| 154 | regulation of Rap GTPase activity (GO:0032317) | 2.48354015 |
| 155 | imidazole-containing compound metabolic process (GO:0052803) | 2.46153678 |
| 156 | negative regulation of necroptotic process (GO:0060546) | 2.46000050 |
| 157 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.45367597 |
| 158 | hepatocyte apoptotic process (GO:0097284) | 2.44266019 |
| 159 | regulation of memory T cell differentiation (GO:0043380) | 2.43960429 |
| 160 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.43846262 |
| 161 | innate immune response in mucosa (GO:0002227) | 2.43646495 |
| 162 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.43619197 |
| 163 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.43202658 |
| 164 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.42978047 |
| 165 | response to interleukin-15 (GO:0070672) | 2.42194822 |
| 166 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.41452968 |
| 167 | positive regulation of mast cell activation (GO:0033005) | 2.39087855 |
| 168 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.37284330 |
| 169 | defense response to fungus (GO:0050832) | 2.37105658 |
| 170 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.37011652 |
| 171 | neutrophil mediated immunity (GO:0002446) | 2.35921537 |
| 172 | activated T cell proliferation (GO:0050798) | 2.34751559 |
| 173 | leukocyte aggregation (GO:0070486) | 2.34376702 |
| 174 | neutrophil activation (GO:0042119) | 2.34205091 |
| 175 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.32570086 |
| 176 | phospholipid dephosphorylation (GO:0046839) | 2.30565860 |
| 177 | hypotonic response (GO:0006971) | 2.27592624 |
| 178 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.27454116 |
| 179 | negative regulation of adaptive immune response (GO:0002820) | 2.27301480 |
| 180 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.27290655 |
| 181 | response to peptidoglycan (GO:0032494) | 2.27195221 |
| 182 | import into cell (GO:0098657) | 2.27092351 |
| 183 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.26614168 |
| 184 | detection of biotic stimulus (GO:0009595) | 2.25516322 |
| 185 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.22035879 |
| 186 | response to epinephrine (GO:0071871) | 2.21698232 |
| 187 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.18294672 |
| 188 | megakaryocyte development (GO:0035855) | 2.17475663 |
| 189 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.17222708 |
| 190 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.17222708 |
| 191 | modulation by symbiont of host immune response (GO:0052553) | 2.17222708 |
| 192 | positive regulation by symbiont of host defense response (GO:0052509) | 2.17222708 |
| 193 | modulation by symbiont of host defense response (GO:0052031) | 2.17222708 |
| 194 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.17222708 |
| 195 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.16371030 |
| 196 | negative regulation of complement activation (GO:0045916) | 2.15682598 |
| 197 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.15520871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.56915078 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.42733508 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.71425648 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.54891604 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.26939287 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.24886360 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.23209264 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.18310165 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.17330564 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.03004368 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.84936732 |
| 12 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.50593370 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.49779613 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.46325971 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.41336251 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.35501212 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.22776927 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.20673628 |
| 19 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.19696696 |
| 20 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.10142832 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07875491 |
| 22 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.07755534 |
| 23 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.06004249 |
| 24 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.05355110 |
| 25 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.02020749 |
| 26 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.01618359 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.01182069 |
| 28 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.95016460 |
| 29 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.93235167 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91054766 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88322008 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.84754072 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.80611723 |
| 34 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.78891112 |
| 35 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.78871451 |
| 36 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.78275150 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77890908 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.76969270 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.76394494 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.73826905 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.73311455 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.73004439 |
| 43 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.71179430 |
| 44 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.70784804 |
| 45 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.67404295 |
| 46 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.65984900 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.65421056 |
| 48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.65086797 |
| 49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.58348244 |
| 50 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.56737741 |
| 51 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.56737741 |
| 52 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56349505 |
| 53 | MYC_22102868_ChIP-Seq_BL_Human | 1.55285762 |
| 54 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.54522073 |
| 55 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.54195930 |
| 56 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.53616206 |
| 57 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.53065943 |
| 58 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.52277589 |
| 59 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52150041 |
| 60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.51429906 |
| 61 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.49644100 |
| 62 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49161175 |
| 63 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.47842445 |
| 64 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.47346299 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46667328 |
| 66 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.42947290 |
| 67 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.41731662 |
| 68 | MYB_26560356_Chip-Seq_TH2_Human | 1.41484676 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40870953 |
| 70 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.40689151 |
| 71 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38351802 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.37233304 |
| 73 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.36124809 |
| 74 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34703452 |
| 75 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34691667 |
| 76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28768829 |
| 77 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27772328 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27124764 |
| 79 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.26012942 |
| 80 | UTX_26944678_Chip-Seq_JUKART_Human | 1.25044617 |
| 81 | MAF_26560356_Chip-Seq_TH1_Human | 1.24550938 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23714356 |
| 83 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22496385 |
| 84 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.22492236 |
| 85 | MAF_26560356_Chip-Seq_TH2_Human | 1.21192934 |
| 86 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20820101 |
| 87 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.20788778 |
| 88 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.18152357 |
| 89 | MYB_26560356_Chip-Seq_TH1_Human | 1.17370257 |
| 90 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16748069 |
| 91 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15785869 |
| 92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15774536 |
| 93 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.13932119 |
| 94 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.13690013 |
| 95 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.13272181 |
| 96 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.11791851 |
| 97 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.10275445 |
| 98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09668010 |
| 99 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.09120090 |
| 100 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07512005 |
| 101 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.07127653 |
| 102 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.06791747 |
| 103 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.05049586 |
| 104 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.03393998 |
| 105 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.02974163 |
| 106 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02671296 |
| 107 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02636778 |
| 108 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99059411 |
| 109 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.99032936 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97494835 |
| 111 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.97178453 |
| 112 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96921334 |
| 113 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.96633190 |
| 114 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96118207 |
| 115 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95976713 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95005989 |
| 117 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.94678538 |
| 118 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93590443 |
| 119 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.91820379 |
| 120 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91655898 |
| 121 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89841074 |
| 122 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.89325773 |
| 123 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89055301 |
| 124 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88459706 |
| 125 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88155469 |
| 126 | AR_25329375_ChIP-Seq_VCAP_Human | 0.88013159 |
| 127 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86522731 |
| 128 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.86401050 |
| 129 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.85272078 |
| 130 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.85091742 |
| 131 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.85087733 |
| 132 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.84992946 |
| 133 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.84962968 |
| 134 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.84694470 |
| 135 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.84358509 |
| 136 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84022480 |
| 137 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.82505503 |
| 138 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.82265446 |
| 139 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.82074045 |
| 140 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82058691 |
| 141 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.82047088 |
| 142 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81528916 |
| 143 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.81352447 |
| 144 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.81225954 |
| 145 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.80367013 |
| 146 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.79456452 |
| 147 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.78539298 |
| 148 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.76021336 |
| 149 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75093242 |
| 150 | P300_19829295_ChIP-Seq_ESCs_Human | 0.74981083 |
| 151 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.74570405 |
| 152 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.73641435 |
| 153 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.73088920 |
| 154 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.72882918 |
| 155 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.72882918 |
| 156 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.71913541 |
| 157 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.69771217 |
| 158 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.69588396 |
| 159 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.69458181 |
| 160 | KDM2B_26808549_Chip-Seq_K562_Human | 0.69112590 |
| 161 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.68806768 |
| 162 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.68504552 |
| 163 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.67654584 |
| 164 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.67654584 |
| 165 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.67525181 |
| 166 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.66501534 |
| 167 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.66278406 |
| 168 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.66051043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.04909241 |
| 2 | MP0005360_urolithiasis | 4.07755573 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.93665650 |
| 4 | MP0005365_abnormal_bile_salt | 3.91220445 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.43983666 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 3.31106789 |
| 7 | MP0004147_increased_porphyrin_level | 2.85600850 |
| 8 | MP0005083_abnormal_biliary_tract | 2.77501973 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.69894180 |
| 10 | MP0003880_abnormal_central_pattern | 2.67971345 |
| 11 | MP0000569_abnormal_digit_pigmentation | 2.66755609 |
| 12 | MP0003656_abnormal_erythrocyte_physiolo | 2.64725993 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.54926266 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.40149014 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.35848419 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.30215814 |
| 17 | MP0003436_decreased_susceptibility_to | 2.25443695 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.10837244 |
| 19 | MP0003724_increased_susceptibility_to | 2.08730344 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.07189636 |
| 21 | MP0002132_abnormal_respiratory_system | 2.03484252 |
| 22 | MP0002736_abnormal_nociception_after | 1.98422162 |
| 23 | MP0005451_abnormal_body_composition | 1.95273831 |
| 24 | MP0003806_abnormal_nucleotide_metabolis | 1.93936594 |
| 25 | MP0005332_abnormal_amino_acid | 1.93396611 |
| 26 | MP0003763_abnormal_thymus_physiology | 1.93204450 |
| 27 | MP0009745_abnormal_behavioral_response | 1.93096787 |
| 28 | MP0001666_abnormal_nutrient_absorption | 1.90744901 |
| 29 | MP0004270_analgesia | 1.89462108 |
| 30 | MP0003329_amyloid_beta_deposits | 1.87119891 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.87036555 |
| 32 | MP0009046_muscle_twitch | 1.86810674 |
| 33 | MP0002064_seizures | 1.85032795 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.78808808 |
| 35 | MP0003252_abnormal_bile_duct | 1.78658450 |
| 36 | MP0000015_abnormal_ear_pigmentation | 1.73176991 |
| 37 | MP0002909_abnormal_adrenal_gland | 1.69526828 |
| 38 | MP0002733_abnormal_thermal_nociception | 1.68674385 |
| 39 | MP0002272_abnormal_nervous_system | 1.67321392 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.67183920 |
| 41 | MP0003303_peritoneal_inflammation | 1.66523440 |
| 42 | MP0004185_abnormal_adipocyte_glucose | 1.66188896 |
| 43 | MP0002063_abnormal_learning/memory/cond | 1.64838857 |
| 44 | MP0009840_abnormal_foam_cell | 1.64694238 |
| 45 | MP0003045_fibrosis | 1.64603545 |
| 46 | MP0002734_abnormal_mechanical_nocicepti | 1.64500667 |
| 47 | MP0002837_dystrophic_cardiac_calcinosis | 1.63885920 |
| 48 | MP0002971_abnormal_brown_adipose | 1.62920646 |
| 49 | MP0006036_abnormal_mitochondrial_physio | 1.61877240 |
| 50 | MP0002822_catalepsy | 1.60397587 |
| 51 | MP0002118_abnormal_lipid_homeostasis | 1.59946811 |
| 52 | MP0003868_abnormal_feces_composition | 1.58623235 |
| 53 | MP0003195_calcinosis | 1.58616323 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.55522080 |
| 55 | MP0006276_abnormal_autonomic_nervous | 1.53869914 |
| 56 | MP0002419_abnormal_innate_immunity | 1.52434995 |
| 57 | MP0000685_abnormal_immune_system | 1.51677403 |
| 58 | MP0001984_abnormal_olfaction | 1.47208853 |
| 59 | MP0005535_abnormal_body_temperature | 1.46973769 |
| 60 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.46382400 |
| 61 | MP0005075_abnormal_melanosome_morpholog | 1.44512520 |
| 62 | MP0001800_abnormal_humoral_immune | 1.44113413 |
| 63 | MP0005025_abnormal_response_to | 1.42851526 |
| 64 | MP0001501_abnormal_sleep_pattern | 1.42680424 |
| 65 | MP0001970_abnormal_pain_threshold | 1.41341405 |
| 66 | MP0001661_extended_life_span | 1.40207064 |
| 67 | MP0002572_abnormal_emotion/affect_behav | 1.39863909 |
| 68 | MP0001545_abnormal_hematopoietic_system | 1.39597886 |
| 69 | MP0005397_hematopoietic_system_phenotyp | 1.39597886 |
| 70 | MP0001348_abnormal_lacrimal_gland | 1.38330678 |
| 71 | MP0001851_eye_inflammation | 1.37291952 |
| 72 | MP0003690_abnormal_glial_cell | 1.37175385 |
| 73 | MP0004381_abnormal_hair_follicle | 1.35989688 |
| 74 | MP0002067_abnormal_sensory_capabilities | 1.35869625 |
| 75 | MP0002398_abnormal_bone_marrow | 1.35110829 |
| 76 | MP0001790_abnormal_immune_system | 1.35042293 |
| 77 | MP0005387_immune_system_phenotype | 1.35042293 |
| 78 | MP0005058_abnormal_lysosome_morphology | 1.33081888 |
| 79 | MP0005174_abnormal_tail_pigmentation | 1.28234022 |
| 80 | MP0001873_stomach_inflammation | 1.26564033 |
| 81 | MP0001764_abnormal_homeostasis | 1.26258668 |
| 82 | MP0003191_abnormal_cellular_cholesterol | 1.26189994 |
| 83 | MP0004142_abnormal_muscle_tone | 1.26117971 |
| 84 | MP0004130_abnormal_muscle_cell | 1.25673573 |
| 85 | MP0005636_abnormal_mineral_homeostasis | 1.25599576 |
| 86 | MP0009780_abnormal_chondrocyte_physiolo | 1.25488698 |
| 87 | MP0002420_abnormal_adaptive_immunity | 1.25271817 |
| 88 | MP0008260_abnormal_autophagy | 1.24858451 |
| 89 | MP0001486_abnormal_startle_reflex | 1.24454182 |
| 90 | MP0005646_abnormal_pituitary_gland | 1.24253403 |
| 91 | MP0008057_abnormal_DNA_replication | 1.23080689 |
| 92 | MP0000703_abnormal_thymus_morphology | 1.21984998 |
| 93 | MP0001819_abnormal_immune_cell | 1.21896965 |
| 94 | MP0002876_abnormal_thyroid_physiology | 1.21542026 |
| 95 | MP0003828_pulmonary_edema | 1.20479311 |
| 96 | MP0000604_amyloidosis | 1.20103957 |
| 97 | MP0002723_abnormal_immune_serum | 1.19842297 |
| 98 | MP0000609_abnormal_liver_physiology | 1.19479378 |
| 99 | MP0005000_abnormal_immune_tolerance | 1.18597813 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 1.18258871 |
| 101 | MP0005319_abnormal_enzyme/_coenzyme | 1.18241594 |
| 102 | MP0005666_abnormal_adipose_tissue | 1.17723282 |
| 103 | MP0001440_abnormal_grooming_behavior | 1.16653771 |
| 104 | MP0003866_abnormal_defecation | 1.15320948 |
| 105 | MP0004019_abnormal_vitamin_homeostasis | 1.14272048 |
| 106 | MP0009115_abnormal_fat_cell | 1.14097117 |
| 107 | MP0002009_preneoplasia | 1.14006420 |
| 108 | MP0003879_abnormal_hair_cell | 1.12546770 |
| 109 | MP0002078_abnormal_glucose_homeostasis | 1.11185639 |
| 110 | MP0008872_abnormal_physiological_respon | 1.10404866 |
| 111 | MP0002332_abnormal_exercise_endurance | 1.09728985 |
| 112 | MP0002722_abnormal_immune_system | 1.08871865 |
| 113 | MP0008569_lethality_at_weaning | 1.08563338 |
| 114 | MP0004808_abnormal_hematopoietic_stem | 1.08390674 |
| 115 | MP0005084_abnormal_gallbladder_morpholo | 1.06260809 |
| 116 | MP0005551_abnormal_eye_electrophysiolog | 1.05878748 |
| 117 | MP0009785_altered_susceptibility_to | 1.04990878 |
| 118 | MP0005375_adipose_tissue_phenotype | 1.04910824 |
| 119 | MP0000371_diluted_coat_color | 1.04807411 |
| 120 | MP0003633_abnormal_nervous_system | 1.04511746 |
| 121 | MP0000716_abnormal_immune_system | 1.04482926 |
| 122 | MP0001502_abnormal_circadian_rhythm | 1.04094300 |
| 123 | MP0008874_decreased_physiological_sensi | 1.03376543 |
| 124 | MP0000003_abnormal_adipose_tissue | 1.03275596 |
| 125 | MP0000013_abnormal_adipose_tissue | 1.03157483 |
| 126 | MP0004145_abnormal_muscle_electrophysio | 1.02578679 |
| 127 | MP0004924_abnormal_behavior | 1.00924097 |
| 128 | MP0005386_behavior/neurological_phenoty | 1.00924097 |
| 129 | MP0000689_abnormal_spleen_morphology | 1.00516539 |
| 130 | MP0001533_abnormal_skeleton_physiology | 0.99464156 |
| 131 | MP0005423_abnormal_somatic_nervous | 0.99224549 |
| 132 | MP0004043_abnormal_pH_regulation | 0.97701187 |
| 133 | MP0002877_abnormal_melanocyte_morpholog | 0.96325449 |
| 134 | MP0002006_tumorigenesis | 0.95591518 |
| 135 | MP0002452_abnormal_antigen_presenting | 0.95391981 |
| 136 | MP0002429_abnormal_blood_cell | 0.94138794 |
| 137 | MP0004215_abnormal_myocardial_fiber | 0.94074357 |
| 138 | MP0010155_abnormal_intestine_physiology | 0.93687179 |
| 139 | MP0004947_skin_inflammation | 0.92600094 |
| 140 | MP0002229_neurodegeneration | 0.92353861 |
| 141 | MP0000465_gastrointestinal_hemorrhage | 0.92094669 |
| 142 | MP0002405_respiratory_system_inflammati | 0.89081423 |
| 143 | MP0002557_abnormal_social/conspecific_i | 0.87719398 |
| 144 | MP0009643_abnormal_urine_homeostasis | 0.86830125 |
| 145 | MP0000681_abnormal_thyroid_gland | 0.86445774 |
| 146 | MP0001765_abnormal_ion_homeostasis | 0.84943260 |
| 147 | MP0005670_abnormal_white_adipose | 0.84720562 |
| 148 | MP0003787_abnormal_imprinting | 0.82698767 |
| 149 | MP0001905_abnormal_dopamine_level | 0.81640702 |
| 150 | MP0008961_abnormal_basal_metabolism | 0.81630062 |
| 151 | MP0002138_abnormal_hepatobiliary_system | 0.81105587 |
| 152 | MP0002066_abnormal_motor_capabilities/c | 0.79789728 |
| 153 | MP0001845_abnormal_inflammatory_respons | 0.79417193 |
| 154 | MP0002090_abnormal_vision | 0.79192632 |
| 155 | MP0002970_abnormal_white_adipose | 0.79176619 |
| 156 | MP0000230_abnormal_systemic_arterial | 0.77722723 |
| 157 | MP0001958_emphysema | 0.77693068 |
| 158 | MP0003631_nervous_system_phenotype | 0.77062587 |
| 159 | MP0002184_abnormal_innervation | 0.76987022 |
| 160 | MP0000955_abnormal_spinal_cord | 0.76704948 |
| 161 | MP0004811_abnormal_neuron_physiology | 0.75924994 |
| 162 | MP0000747_muscle_weakness | 0.75507048 |
| 163 | MP0002693_abnormal_pancreas_physiology | 0.74946424 |
| 164 | MP0001664_abnormal_digestion | 0.74081435 |
| 165 | MP0003953_abnormal_hormone_level | 0.73488033 |
| 166 | MP0002069_abnormal_eating/drinking_beha | 0.73228427 |
| 167 | MP0004036_abnormal_muscle_relaxation | 0.73122517 |
| 168 | MP0000751_myopathy | 0.73014312 |
| 169 | MP0005448_abnormal_energy_balance | 0.71800053 |
| 170 | MP0005334_abnormal_fat_pad | 0.71065747 |
| 171 | MP0009642_abnormal_blood_homeostasis | 0.70239369 |
| 172 | MP0003011_delayed_dark_adaptation | 0.69745326 |
| 173 | MP0001986_abnormal_taste_sensitivity | 0.68884503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.21703121 |
| 2 | Hypochromic anemia (HP:0001931) | 4.14992580 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.04513029 |
| 4 | Myokymia (HP:0002411) | 3.91595597 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 3.90431238 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 3.77021081 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 3.74511845 |
| 8 | Xanthomatosis (HP:0000991) | 3.63683717 |
| 9 | Focal motor seizures (HP:0011153) | 3.62752906 |
| 10 | Prolonged bleeding time (HP:0003010) | 3.55636029 |
| 11 | Ketosis (HP:0001946) | 3.53103215 |
| 12 | Cholecystitis (HP:0001082) | 3.35904561 |
| 13 | Abnormal gallbladder physiology (HP:0012438) | 3.35904561 |
| 14 | Visual hallucinations (HP:0002367) | 3.32203426 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 3.27028993 |
| 16 | Myositis (HP:0100614) | 3.26186546 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.25648076 |
| 18 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.24841852 |
| 19 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.24097370 |
| 20 | Hyperbilirubinemia (HP:0002904) | 3.23350804 |
| 21 | Gastrointestinal infarctions (HP:0005244) | 3.23022538 |
| 22 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.22319174 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.19033604 |
| 24 | Hyperammonemia (HP:0001987) | 3.16343416 |
| 25 | Ketoacidosis (HP:0001993) | 3.13745579 |
| 26 | Neonatal hypoglycemia (HP:0001998) | 3.07596268 |
| 27 | Microcytic anemia (HP:0001935) | 3.03734245 |
| 28 | Poikilocytosis (HP:0004447) | 3.02214650 |
| 29 | Gout (HP:0001997) | 3.01311899 |
| 30 | Gingival bleeding (HP:0000225) | 3.01073707 |
| 31 | Recurrent bacterial skin infections (HP:0005406) | 3.00805875 |
| 32 | Acanthocytosis (HP:0001927) | 2.99877529 |
| 33 | Optic neuritis (HP:0100653) | 2.95182748 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 2.95182748 |
| 35 | Abnormality of the fingertips (HP:0001211) | 2.94987566 |
| 36 | Orchitis (HP:0100796) | 2.94093074 |
| 37 | Cholelithiasis (HP:0001081) | 2.92554288 |
| 38 | Hyperglycinemia (HP:0002154) | 2.92024601 |
| 39 | Hypoglycemic coma (HP:0001325) | 2.89876756 |
| 40 | Recurrent abscess formation (HP:0002722) | 2.87902258 |
| 41 | Abnormal gallbladder morphology (HP:0012437) | 2.81518699 |
| 42 | Slow saccadic eye movements (HP:0000514) | 2.80870433 |
| 43 | Complement deficiency (HP:0004431) | 2.79412366 |
| 44 | Spontaneous hematomas (HP:0007420) | 2.75083398 |
| 45 | Papilledema (HP:0001085) | 2.72927577 |
| 46 | Focal seizures (HP:0007359) | 2.71521944 |
| 47 | Status epilepticus (HP:0002133) | 2.69438326 |
| 48 | Polycythemia (HP:0001901) | 2.66988579 |
| 49 | Epistaxis (HP:0000421) | 2.65646674 |
| 50 | Abnormality of the common coagulation pathway (HP:0010990) | 2.64811192 |
| 51 | Hyperglycinuria (HP:0003108) | 2.62100815 |
| 52 | Abnormality of the intrinsic pathway (HP:0010989) | 2.59980936 |
| 53 | Febrile seizures (HP:0002373) | 2.59882550 |
| 54 | Atonic seizures (HP:0010819) | 2.58983002 |
| 55 | Ocular albinism (HP:0001107) | 2.58368517 |
| 56 | Hypolipoproteinemia (HP:0010981) | 2.55330640 |
| 57 | Progressive cerebellar ataxia (HP:0002073) | 2.54818801 |
| 58 | Generalized tonic-clonic seizures (HP:0002069) | 2.54083417 |
| 59 | Absence seizures (HP:0002121) | 2.52369502 |
| 60 | Episodic fever (HP:0001954) | 2.50903841 |
| 61 | Metabolic acidosis (HP:0001942) | 2.50322049 |
| 62 | Abnormality of glycine metabolism (HP:0010895) | 2.47232907 |
| 63 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.47232907 |
| 64 | Reticulocytosis (HP:0001923) | 2.47184247 |
| 65 | Recurrent fungal infections (HP:0002841) | 2.44061016 |
| 66 | Hypoglycemic seizures (HP:0002173) | 2.41561497 |
| 67 | Conjugated hyperbilirubinemia (HP:0002908) | 2.40818117 |
| 68 | Autoimmune hemolytic anemia (HP:0001890) | 2.39947314 |
| 69 | Epileptic encephalopathy (HP:0200134) | 2.39452171 |
| 70 | Abnormality of T cell number (HP:0011839) | 2.38345010 |
| 71 | Hypoalphalipoproteinemia (HP:0003233) | 2.38188450 |
| 72 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.37608588 |
| 73 | Cerebral edema (HP:0002181) | 2.37335079 |
| 74 | Delayed CNS myelination (HP:0002188) | 2.36957125 |
| 75 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.35274831 |
| 76 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.35250691 |
| 77 | Recurrent skin infections (HP:0001581) | 2.35166524 |
| 78 | Anxiety (HP:0000739) | 2.34019168 |
| 79 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.33123011 |
| 80 | Scanning speech (HP:0002168) | 2.31373986 |
| 81 | Stomatitis (HP:0010280) | 2.30730253 |
| 82 | Action tremor (HP:0002345) | 2.30355679 |
| 83 | Postural instability (HP:0002172) | 2.30219057 |
| 84 | Neonatal onset (HP:0003623) | 2.29700750 |
| 85 | Sensorimotor neuropathy (HP:0007141) | 2.25979421 |
| 86 | Fat malabsorption (HP:0002630) | 2.25094537 |
| 87 | Abnormality of iron homeostasis (HP:0011031) | 2.23408863 |
| 88 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.21650739 |
| 89 | Hepatic necrosis (HP:0002605) | 2.21303334 |
| 90 | Gingivitis (HP:0000230) | 2.20754249 |
| 91 | Peritonitis (HP:0002586) | 2.20353988 |
| 92 | Dialeptic seizures (HP:0011146) | 2.19817684 |
| 93 | Joint hemorrhage (HP:0005261) | 2.19250131 |
| 94 | Acute encephalopathy (HP:0006846) | 2.18256070 |
| 95 | Keratoconjunctivitis sicca (HP:0001097) | 2.17271896 |
| 96 | Ventricular fibrillation (HP:0001663) | 2.16265396 |
| 97 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.15693790 |
| 98 | Inflammation of the large intestine (HP:0002037) | 2.15554206 |
| 99 | Abnormal hemoglobin (HP:0011902) | 2.15060161 |
| 100 | Depression (HP:0000716) | 2.14860722 |
| 101 | Pheochromocytoma (HP:0002666) | 2.14808639 |
| 102 | Lethargy (HP:0001254) | 2.13994960 |
| 103 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.13776422 |
| 104 | Hypochromic microcytic anemia (HP:0004840) | 2.12953696 |
| 105 | Urticaria (HP:0001025) | 2.12930213 |
| 106 | Exercise-induced myalgia (HP:0003738) | 2.12775034 |
| 107 | Abnormality of methionine metabolism (HP:0010901) | 2.11238430 |
| 108 | Granulocytopenia (HP:0001913) | 2.11018253 |
| 109 | T lymphocytopenia (HP:0005403) | 2.10318612 |
| 110 | Iris hypopigmentation (HP:0007730) | 2.10112741 |
| 111 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.09716825 |
| 112 | Neuroendocrine neoplasm (HP:0100634) | 2.09319507 |
| 113 | Brushfield spots (HP:0001088) | 2.08429919 |
| 114 | Gastrointestinal inflammation (HP:0004386) | 2.07568885 |
| 115 | Colitis (HP:0002583) | 2.06701754 |
| 116 | Fatigue (HP:0012378) | 2.05378238 |
| 117 | Dysostosis multiplex (HP:0000943) | 2.05128129 |
| 118 | Craniofacial dystonia (HP:0012179) | 2.05111163 |
| 119 | Epidermoid cyst (HP:0200040) | 2.04338098 |
| 120 | Focal dystonia (HP:0004373) | 2.04244900 |
| 121 | Abnormality of T cell physiology (HP:0011840) | 2.03419305 |
| 122 | Hepatocellular necrosis (HP:0001404) | 2.03368437 |
| 123 | Ragged-red muscle fibers (HP:0003200) | 2.03268366 |
| 124 | Dicarboxylic aciduria (HP:0003215) | 2.02834632 |
| 125 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.02834632 |
| 126 | Abnormality of the gallbladder (HP:0005264) | 2.02770941 |
| 127 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.02484256 |
| 128 | Meningitis (HP:0001287) | 2.02368094 |
| 129 | Torticollis (HP:0000473) | 2.02291006 |
| 130 | Progressive inability to walk (HP:0002505) | 2.02270296 |
| 131 | Spontaneous abortion (HP:0005268) | 2.01997387 |
| 132 | Supranuclear gaze palsy (HP:0000605) | 2.01446573 |
| 133 | Dysmetric saccades (HP:0000641) | 2.00939475 |
| 134 | Acne (HP:0001061) | 2.00822329 |
| 135 | Myoglobinuria (HP:0002913) | 1.99582821 |
| 136 | Hyperventilation (HP:0002883) | 1.99131928 |
| 137 | Pustule (HP:0200039) | 1.99047817 |
| 138 | Abnormality of serum amino acid levels (HP:0003112) | 1.98044436 |
| 139 | Petechiae (HP:0000967) | 1.97167090 |
| 140 | Increased IgE level (HP:0003212) | 1.96040263 |
| 141 | Cerebral hemorrhage (HP:0001342) | 1.95826423 |
| 142 | Acute hepatic failure (HP:0006554) | 1.95161161 |
| 143 | Arterial thrombosis (HP:0004420) | 1.94832504 |
| 144 | Paralysis (HP:0003470) | 1.94007948 |
| 145 | Dysdiadochokinesis (HP:0002075) | 1.93956633 |
| 146 | Abnormality of purine metabolism (HP:0004352) | 1.93163176 |
| 147 | Lactic acidosis (HP:0003128) | 1.92981456 |
| 148 | Late onset (HP:0003584) | 1.92748212 |
| 149 | Hypercholesterolemia (HP:0003124) | 1.92692986 |
| 150 | Keratoconjunctivitis (HP:0001096) | 1.91574167 |
| 151 | Ankle clonus (HP:0011448) | 1.91011567 |
| 152 | Abnormality of T cells (HP:0002843) | 1.90851190 |
| 153 | Impaired social interactions (HP:0000735) | 1.90100480 |
| 154 | Abnormal social behavior (HP:0012433) | 1.90100480 |
| 155 | Increased muscle lipid content (HP:0009058) | 1.89659169 |
| 156 | Irritability (HP:0000737) | 1.89579833 |
| 157 | Recurrent cutaneous fungal infections (HP:0011370) | 1.89462872 |
| 158 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.89462872 |
| 159 | Increased serum ferritin (HP:0003281) | 1.89382386 |
| 160 | Purpura (HP:0000979) | 1.88344248 |
| 161 | Vomiting (HP:0002013) | 1.88263837 |
| 162 | Vasculitis (HP:0002633) | 1.88196769 |
| 163 | Bradykinesia (HP:0002067) | 1.85268540 |
| 164 | Glucose intolerance (HP:0000833) | 1.84986930 |
| 165 | Generalized hyperpigmentation (HP:0007440) | 1.84875432 |
| 166 | Pulmonary embolism (HP:0002204) | 1.84842086 |
| 167 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.84143459 |
| 168 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.84039394 |
| 169 | Hyperthyroidism (HP:0000836) | 1.83004877 |
| 170 | Albinism (HP:0001022) | 1.82646143 |
| 171 | Obstructive lung disease (HP:0006536) | 1.79707670 |
| 172 | Chronic obstructive pulmonary disease (HP:0006510) | 1.79707670 |
| 173 | Abnormality of macrophages (HP:0004311) | 1.78974631 |
| 174 | Arthropathy (HP:0003040) | 1.78573841 |
| 175 | Obstructive sleep apnea (HP:0002870) | 1.77549215 |
| 176 | Recurrent viral infections (HP:0004429) | 1.77504940 |
| 177 | Rectal prolapse (HP:0002035) | 1.76287914 |
| 178 | Amyloidosis (HP:0011034) | 1.76058723 |
| 179 | Pulmonary infiltrates (HP:0002113) | 1.75008237 |
| 180 | Encephalitis (HP:0002383) | 1.74743804 |
| 181 | Bruising susceptibility (HP:0000978) | 1.74515698 |
| 182 | Osteomyelitis (HP:0002754) | 1.73613966 |
| 183 | Cellulitis (HP:0100658) | 1.72794738 |
| 184 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.72100986 |
| 185 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.72100986 |
| 186 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.72100986 |
| 187 | Abnormality of saccadic eye movements (HP:0000570) | 1.71349095 |
| 188 | Toxemia of pregnancy (HP:0100603) | 1.70699648 |
| 189 | Autoimmune thrombocytopenia (HP:0001973) | 1.70592463 |
| 190 | Hypoplasia of the thymus (HP:0000778) | 1.70212263 |
| 191 | Testicular neoplasm (HP:0010788) | 1.68406475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.56837663 |
| 2 | BCKDK | 3.38541119 |
| 3 | PINK1 | 2.83489961 |
| 4 | MAP2K4 | 2.79900924 |
| 5 | ARAF | 2.73446419 |
| 6 | MAP3K9 | 2.68275050 |
| 7 | KSR2 | 2.65880926 |
| 8 | MAP3K12 | 2.63374145 |
| 9 | MAP3K4 | 2.49507357 |
| 10 | MAP2K7 | 2.44904051 |
| 11 | EPHA4 | 2.30362808 |
| 12 | RIPK4 | 2.24044429 |
| 13 | MINK1 | 2.18981749 |
| 14 | PRPF4B | 2.02986353 |
| 15 | AKT3 | 2.01438202 |
| 16 | DAPK2 | 1.99986555 |
| 17 | GRK5 | 1.90254002 |
| 18 | ICK | 1.80657031 |
| 19 | NTRK1 | 1.72646965 |
| 20 | MAP3K13 | 1.72043763 |
| 21 | PAK6 | 1.71844368 |
| 22 | BMPR2 | 1.68555775 |
| 23 | TYK2 | 1.65875436 |
| 24 | BLK | 1.62648175 |
| 25 | TNIK | 1.58406828 |
| 26 | INSRR | 1.53126762 |
| 27 | RAF1 | 1.53071682 |
| 28 | CDK19 | 1.52778282 |
| 29 | PHKG2 | 1.52535034 |
| 30 | PHKG1 | 1.52535034 |
| 31 | CAMKK2 | 1.51226518 |
| 32 | CAMKK1 | 1.48192438 |
| 33 | LMTK2 | 1.46003682 |
| 34 | MAP3K2 | 1.45936020 |
| 35 | CAMK1D | 1.31515644 |
| 36 | SYK | 1.30199150 |
| 37 | JAK1 | 1.29722714 |
| 38 | MAP3K3 | 1.29343880 |
| 39 | ZAP70 | 1.29335799 |
| 40 | CAMK1G | 1.25992232 |
| 41 | MAP3K1 | 1.25966179 |
| 42 | RET | 1.23699889 |
| 43 | SCYL2 | 1.22587468 |
| 44 | TAOK1 | 1.21817716 |
| 45 | PRKD3 | 1.18995071 |
| 46 | WNK1 | 1.18218310 |
| 47 | TNK2 | 1.17351161 |
| 48 | CDK5 | 1.15664527 |
| 49 | FES | 1.13963501 |
| 50 | DAPK1 | 1.13580283 |
| 51 | MAPKAPK5 | 1.11163194 |
| 52 | TRPM7 | 1.10782737 |
| 53 | FGFR3 | 1.06886874 |
| 54 | CDK12 | 1.06309617 |
| 55 | PRKCG | 1.05089844 |
| 56 | MAP4K1 | 1.04262138 |
| 57 | PKN2 | 1.03604669 |
| 58 | TAOK3 | 1.02925692 |
| 59 | STK38 | 0.99882477 |
| 60 | BTK | 0.99132224 |
| 61 | PIK3CA | 0.98138982 |
| 62 | STK11 | 0.97681131 |
| 63 | PDK1 | 0.95295414 |
| 64 | MARK1 | 0.92855698 |
| 65 | MARK2 | 0.92297143 |
| 66 | MAP3K11 | 0.91244037 |
| 67 | IRAK4 | 0.90280020 |
| 68 | MAP2K1 | 0.88524359 |
| 69 | MUSK | 0.87706742 |
| 70 | CAMK1 | 0.87691791 |
| 71 | PDPK1 | 0.86889843 |
| 72 | JAK3 | 0.86310848 |
| 73 | SIK2 | 0.85799574 |
| 74 | HCK | 0.85794875 |
| 75 | NTRK2 | 0.85598130 |
| 76 | MAP3K7 | 0.84797580 |
| 77 | IKBKE | 0.81158774 |
| 78 | HIPK2 | 0.81110619 |
| 79 | CAMK2G | 0.80441905 |
| 80 | PRKD2 | 0.80389591 |
| 81 | MAPKAPK3 | 0.79364703 |
| 82 | TLK1 | 0.79271875 |
| 83 | TEC | 0.78010907 |
| 84 | MAPK12 | 0.76674620 |
| 85 | TIE1 | 0.75724279 |
| 86 | PIM1 | 0.75511483 |
| 87 | EEF2K | 0.75012895 |
| 88 | BRAF | 0.72161744 |
| 89 | TRIB3 | 0.72021622 |
| 90 | CSK | 0.71760618 |
| 91 | PIK3CG | 0.69852414 |
| 92 | SGK494 | 0.69164032 |
| 93 | SGK223 | 0.69164032 |
| 94 | MAP2K6 | 0.68763198 |
| 95 | JAK2 | 0.68652599 |
| 96 | SIK1 | 0.68492841 |
| 97 | SGK1 | 0.68392198 |
| 98 | SGK2 | 0.68096898 |
| 99 | CAMK2A | 0.67294615 |
| 100 | MAP3K14 | 0.65856445 |
| 101 | MAPK11 | 0.65584624 |
| 102 | PAK3 | 0.65400917 |
| 103 | PRKG2 | 0.64593453 |
| 104 | NEK1 | 0.64002710 |
| 105 | PRKCH | 0.61407794 |
| 106 | KSR1 | 0.60455400 |
| 107 | NME1 | 0.60154125 |
| 108 | IRAK1 | 0.59994531 |
| 109 | MAP2K3 | 0.59939609 |
| 110 | MAPK13 | 0.59169454 |
| 111 | MAP2K2 | 0.58659271 |
| 112 | KIT | 0.57598839 |
| 113 | EIF2AK1 | 0.57393489 |
| 114 | LCK | 0.56104464 |
| 115 | CCNB1 | 0.56046012 |
| 116 | CASK | 0.55201964 |
| 117 | ERN1 | 0.53090012 |
| 118 | FGFR4 | 0.52785306 |
| 119 | PDK3 | 0.52766037 |
| 120 | PDK4 | 0.52766037 |
| 121 | PRKAA1 | 0.52590731 |
| 122 | BRSK1 | 0.52162330 |
| 123 | TGFBR2 | 0.52049089 |
| 124 | CAMK4 | 0.51700523 |
| 125 | PRKACG | 0.50395154 |
| 126 | LYN | 0.49867793 |
| 127 | GRK6 | 0.49746491 |
| 128 | IRAK2 | 0.49514930 |
| 129 | PTK2B | 0.49500117 |
| 130 | SGK3 | 0.49334286 |
| 131 | DYRK1A | 0.48926793 |
| 132 | PRKCZ | 0.48889120 |
| 133 | MAP3K6 | 0.48719262 |
| 134 | CAMK2D | 0.45878507 |
| 135 | STK24 | 0.45744999 |
| 136 | ITK | 0.45537558 |
| 137 | MARK3 | 0.45179387 |
| 138 | MAPK10 | 0.43872369 |
| 139 | OXSR1 | 0.43827533 |
| 140 | ADRBK1 | 0.43297781 |
| 141 | RPS6KA2 | 0.43042434 |
| 142 | PRKAA2 | 0.42816069 |
| 143 | PRKACA | 0.42762348 |
| 144 | CAMK2B | 0.40946129 |
| 145 | MAPK4 | 0.40810747 |
| 146 | FRK | 0.40604421 |
| 147 | IKBKB | 0.40020673 |
| 148 | ADRBK2 | 0.39424062 |
| 149 | CDC42BPA | 0.39217519 |
| 150 | PTK6 | 0.38167820 |
| 151 | FGR | 0.38133573 |
| 152 | TXK | 0.37838002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.18962003 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.09379161 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.71990744 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.28494632 |
| 5 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.23663032 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.13343551 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.05011190 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.01968355 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.00718290 |
| 10 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.99394105 |
| 11 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.97302622 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.96579141 |
| 13 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.95398878 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.90218734 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.83488795 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.81564149 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.75135600 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.74757840 |
| 19 | Nicotine addiction_Homo sapiens_hsa05033 | 1.69076064 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.68776486 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.67120886 |
| 22 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.62243492 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.58368422 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.56304005 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.54461191 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.53613286 |
| 27 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.53562971 |
| 28 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.52345032 |
| 29 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.50700940 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.50127074 |
| 31 | Platelet activation_Homo sapiens_hsa04611 | 1.47507693 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46266748 |
| 33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.45398015 |
| 34 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.44838197 |
| 35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.43485923 |
| 36 | GABAergic synapse_Homo sapiens_hsa04727 | 1.43190790 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42139719 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.41275794 |
| 39 | Glioma_Homo sapiens_hsa05214 | 1.40984494 |
| 40 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.40842569 |
| 41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.33841791 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.32746864 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.30675515 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.30351600 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.30175195 |
| 46 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.29746928 |
| 47 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.29447838 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.29073061 |
| 49 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.28932752 |
| 50 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.26546047 |
| 51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.25447239 |
| 52 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.25087326 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24229533 |
| 54 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.22710239 |
| 55 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.21433314 |
| 56 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18872978 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.18050214 |
| 58 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.17503245 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.17409209 |
| 60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.16787350 |
| 61 | Olfactory transduction_Homo sapiens_hsa04740 | 1.16641377 |
| 62 | Insulin secretion_Homo sapiens_hsa04911 | 1.14820217 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.13605831 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13371956 |
| 65 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.12352738 |
| 66 | Circadian entrainment_Homo sapiens_hsa04713 | 1.11572843 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.11370703 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 1.08568046 |
| 69 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.06495366 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.06000171 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 1.05973518 |
| 72 | Salivary secretion_Homo sapiens_hsa04970 | 1.03899601 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.03850992 |
| 74 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.03704293 |
| 75 | Morphine addiction_Homo sapiens_hsa05032 | 1.03405319 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 1.03230748 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02798591 |
| 78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.01590445 |
| 79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01053797 |
| 80 | Long-term potentiation_Homo sapiens_hsa04720 | 1.00987656 |
| 81 | Taste transduction_Homo sapiens_hsa04742 | 1.00316483 |
| 82 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99146848 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.99069286 |
| 84 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.98910613 |
| 85 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.98820796 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.97567285 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.96651907 |
| 88 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.95996977 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94761862 |
| 90 | Leishmaniasis_Homo sapiens_hsa05140 | 0.93706503 |
| 91 | Tuberculosis_Homo sapiens_hsa05152 | 0.93465915 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93410129 |
| 93 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92665903 |
| 94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.90335970 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.89767094 |
| 96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.88017223 |
| 97 | Histidine metabolism_Homo sapiens_hsa00340 | 0.87475248 |
| 98 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.86266941 |
| 99 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.86123377 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85662778 |
| 101 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84757093 |
| 102 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84502741 |
| 103 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.83997127 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83210414 |
| 105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.82602895 |
| 106 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81473636 |
| 107 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.81247567 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81206211 |
| 109 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.80870899 |
| 110 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.79299843 |
| 111 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.79136278 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78437769 |
| 113 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.78347778 |
| 114 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.78123672 |
| 115 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78097720 |
| 116 | Malaria_Homo sapiens_hsa05144 | 0.77573723 |
| 117 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.77069900 |
| 118 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76468006 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76394503 |
| 120 | Endometrial cancer_Homo sapiens_hsa05213 | 0.75806557 |
| 121 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.75052410 |
| 122 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74768614 |
| 123 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.74572158 |
| 124 | Parkinsons disease_Homo sapiens_hsa05012 | 0.73996701 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.73977133 |
| 126 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.73785035 |
| 127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71430943 |
| 128 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.71415828 |
| 129 | Hepatitis C_Homo sapiens_hsa05160 | 0.71041671 |
| 130 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71022163 |
| 131 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.69536585 |
| 132 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68930451 |
| 133 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67742991 |
| 134 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67145282 |
| 135 | Retinol metabolism_Homo sapiens_hsa00830 | 0.67085131 |
| 136 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66681992 |
| 137 | Measles_Homo sapiens_hsa05162 | 0.64228274 |
| 138 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64137359 |
| 139 | Renin secretion_Homo sapiens_hsa04924 | 0.63963414 |
| 140 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63435106 |
| 141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62908043 |
| 142 | Alzheimers disease_Homo sapiens_hsa05010 | 0.62294398 |
| 143 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62285691 |
| 144 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.61577943 |
| 145 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60859513 |
| 146 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.60660301 |
| 147 | Hepatitis B_Homo sapiens_hsa05161 | 0.60334744 |
| 148 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60138160 |
| 149 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59510612 |
| 150 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.58704132 |
| 151 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57908249 |
| 152 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57183845 |
| 153 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57111898 |
| 154 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56246396 |
| 155 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55115463 |
| 156 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.55010945 |
| 157 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54554305 |
| 158 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54469741 |
| 159 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53899357 |
| 160 | Long-term depression_Homo sapiens_hsa04730 | 0.52310909 |
| 161 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51993338 |
| 162 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.50675828 |
| 163 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50082575 |
| 164 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49857594 |
| 165 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46781851 |
| 166 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45598952 |
| 167 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.45492563 |
| 168 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43001173 |
| 169 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42619445 |

